Determination of dandelion capsule on patient with Covid-19 virus

Phase 3

Recruiting

• Conditions: U07.1; Covid-19 infectious disease.; Coronavirus infection :COVID-19, virus identified (a disease diagnosis of COVID-19 confirmed by laboratory testing)

• Registration Number: IRCT20180513039641N2
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients Hospitalized in shaheed Beheshti Hospital in Qom with Covid-19 (their PCR test is positive).
Patients between 18-65 years.
Satisfaction of people to test this drug and its possible side effects.

Exclusion Criteria

History of allergy to plants of asteraceae.
bile duct and intestinal obstruction.
acute cholecystitis, empyema, acute gall bladder inflammation.
Gastrointestinal diseases, gastritis, irritable bowel syndrome.
Diabetes and kidney failure.
Alcohol consumption history (more than 10 grams per day for women and more than 20 grams per day for men).
Pregnant and lactating women and Married women who are in childbearing age and do not use reliable contraception method.
Weight below 50 kg
Uncontrolled underlying diseases such as high blood pressure and ....
Consumers of Lithium, digoxin, corticosteroids such as prednisone, niacin / nicotinic acid, metronidazole, disulfiram, tetracycline and fluoroquinolone antibiotics (such as ciprofloxacin), hypoglycemic drugs, antiplatelet drugs, diuretics, Antacids such as famotidine and s omeprazole.
Consumers of s bloodroot, cat’s claw, chamomile, chaparral, chasteberry, damiana, Echinacea angustifolia, goldenseal, grapefruit juice, licorice, oregano, redclover,St.John’swort, wildcherry, andyucca.

Study & Design

• Study Type: interventional
• Study Design: Not specified